Eupraxia Pharmaceuticals Inc

EPRX

Company Profile

  • Business description

    Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with unmet medical needs.

  • Contact

    201 2067 Cadboro Bay Road
    VictoriaBCV8R 5G4
    CAN

    T: +1 250 590-3968

    https://www.eupraxiapharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    33

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries7,673.90173.70-2.21%
CAC 407,017.50257.45-3.54%
DAX 4020,010.11631.61-3.06%
Dow JONES (US)37,822.402,723.53-6.72%
FTSE 1007,802.51252.47-3.13%
HKSE20,354.442,495.37-10.92%
NASDAQ15,556.05994.56-6.01%
Nikkei 22533,141.70638.88-1.89%
NZX 50 Index11,912.68312.60-2.56%
S&P 5005,041.9432.14-0.63%
S&P/ASX 2007,476.70191.10-2.49%
SSE Composite Index3,114.2017.620.57%

Market Movers